Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07216898 · ClinicalTrials.gov registry record

Clean Beauty in Newark, NJ

A clinical trial of Education and Health Disparities, sponsored by Rutgers, The State University of New Jersey.

Recruiting
Registry status
120
Enrollment target
1
Study location

NCT07216898: Recruiting study of Education and Health Disparities, sponsored by Rutgers, The State University of New Jersey.

NCT07216898 is a study of Education and Health Disparities that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 120 participants, below the 149-participant average among 5 other Education trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07216898, a study of Education and Health Disparities, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.

RECRUITING
Registry status
120 participants
Enrollment target
1
Study location

Study Summary

Every day, consumers use personal care products containing thousands of manmade chemicals. Growing evidence suggests that personal care products specifically marketed to Black women (e.g., hair straighteners and oils, skin lighteners) often contain potentially hazardous chemicals that can interfere with hormones or increase cancer risks. This research focuses on how the investigators can educate and activate community members in Newark, NJ to reduce disparities in exposures occurring through hair products. Leveraging educational clean beauty events hosted by collaborators at Clean Water Action, the investigators will administer surveys on hair product use and attitudes immediately before and after a clean beauty educational intervention. Participants will also complete surveys 3 months post-event to examine any changes in attitudes or behaviors around hair products and their use and safety.

Primary Outcome

After the Clean Beauty intervention event, participants will be asked, "Based on what you learned today, do you think you will make any changes to your hair style, hair routine, or the products you use?" \[Answer choices: Yes/No/Not sure\] We will calculate the percentage of participants who plan to make a change in their hair routine.

Interventions

  • BEHAVIORAL Chemical Exposure Prevention

Study Locations (1)

New Jersey

  • Weequahic Park - Newark

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-11-01
Est. Completion 2026-11-01

What NCT07216898 shows while recruiting

NCT07216898 is an observational study that tracks outcomes without assigning an intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 149-participant average among 5 other Education trials with a reported enrollment target (19% lower).

The record links to 2 conditions, with Education appearing as the primary indexed condition, and to 1 intervention - of which Chemical Exposure Prevention is the first listed.

NCT07216898 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT07216898 about?

NCT07216898 is a clinical study titled "Clean Beauty in Newark, NJ". Every day, consumers use personal care products containing thousands of manmade chemicals. Growing evidence suggests that personal care products specifically marketed to Black women (e.g., hair straighteners and oils, skin lighteners) often contain potentially hazardous chemicals that can interfere ...

What is the current status of trial NCT07216898?

This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2025-11-01. Estimated completion is 2026-11-01.

What conditions does trial NCT07216898 study?

This clinical trial studies the following conditions: Education, Health Disparities.

What interventions are being tested in trial NCT07216898?

The interventions under investigation include: Chemical Exposure Prevention (BEHAVIORAL).

Who is sponsoring clinical trial NCT07216898?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07216898 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Education

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07216898, the US trial registry maintained by the National Library of Medicine. NCT07216898 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.